How has Ultragenyx Pharmaceutical's change in deferred revenue changed year-over-year?

Ultragenyx Pharmaceutical's change in deferred revenue increased by 100.0% year-over-year, from -$404.75K to $0.

What does change in deferred revenue mean?

Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.

Ultragenyx Pharmaceutical RARE Change in Deferred Revenue

Change in Deferred Revenue at other companies

Ionis PharmaceuticalsIONS

-$20.82M-51.8%

Arrowhead ResearchARWR

$163.36M—

CRISPR TherapeuticsCRSP

-$427K+48.2%

ModernaMRNA

$5M+117%

Beam TherapeuticsBEAM

-$6.36M+14.9%

BridgeBio PharmaBBIO

-$2.38M+7.5%

Other financials

Income statement

See full

Revenue$136.0M-2.2%

Operating income-$169.0M-18.2%

Net income-$185.0M-22.5%

EPS (diluted)-$1.84-17.2%

Balance sheet

See full

Cash & equivalents$175.0M+37.8%

Total debt$36.0M-10.8%

Total equity-$236.0M-264%

Total assets$1.3B-1.2%

Cash flow

See full

Operating cash flow-$197.0M-18.7%

CapEx$1.0M0.0%

Free cash flow-$198.0M-18.6%

Valuation

See full

Market cap$2.83B-39.4%

P/S4.2×-3.7×

Profitability

See full

Gross margin97.2%—

Operating margin-83.8%-3.0pp

Net margin-90.9%-2.1pp

FCF margin-75.1%+10.7pp

Returns & leverage

See full

Return on equity-325.6%+36.9pp

Debt / equity3.7×—

Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredLiabilities.

The official record: Ultragenyx Pharmaceutical’s 10-K, filed February 19, 2025, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's change in deferred revenue?: Ultragenyx Pharmaceutical (RARE) reported change in deferred revenue of $0 in Q4 2024.
How has Ultragenyx Pharmaceutical's change in deferred revenue changed year-over-year?: Ultragenyx Pharmaceutical's change in deferred revenue increased by 100.0% year-over-year, from -$404.75K to $0.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.